Targeting headaches and tumors with nano-submarines

Scientists at the Mainz University Medical Center and the Max Planck Institute for Polymer Research (MPI-P) have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue. The scientists have recently published their findings in the renowned scientific journal Nature Nanotechnology.

Professor Volker Mailänder and his team from the Department of Dermatology at the University Medical Center of Johannes Gutenberg University Mainz (JGU) have recently developed an ingenious new of binding antibodies to such drug capsules. “Up to now, we have always had to use elaborate chemical methods to bind these antibodies to nanocapsules,” explained Mailänder. “We have now been able to show that all that you need to do is to combine antibodies and nanocapsules together in an acidified solution.”

Read more at phys.org

Image Credit:  Stefan Schuhmacher 

News This Week

NanoApps Medical Near-Term Projects

NanoApps Medical is investigating the possibility that superparamagnetic nanoparticles (SPIONs) and other classes of nanoparticles (e.g., gold coated nanoshells) might have the capacity to target cancerous tumors, metastasizing cancer cells, pathogens, etc. to deactivate/eliminate [...]

‘Please do not switch me off!’ People heed begging robot

If a little humanoid robot begged you to not shut it off, would you show compassion? In an experiment designed to investigate how people treat robots when they act like humans, many participants struggled [...]

How Artificial Intelligence is Changing Radiology, Pathology

Artificial intelligence and machine learning tools have the potential to analyze large datasets and extract meaningful insights to enhance patient outcomes, an ability that is proving helpful in radiology and pathology. Images obtained by [...]

Nanoparticle-Based Combination Therapy to Treat Breast, Prostate Cancer

Researchers at the University of East Anglia have developed a new nanoparticle-based cancer therapy to deliver a combination therapy directly to cancer cells. The new therapy, which has been demonstrated to make prostate cancer [...]

AI: ChronWell CEO On Why Consolidation in Healthcare Is A Good Thing

When Joe Rubinsztain started gMed, he was admittedly young—only a few years removed from medical school— and he just didn’t understand leadership that well. “I needed to be abreast of everything and understand everything [...]

Artificial Intelligence for Medical Imaging Market to Top $2B

Healthcare organizations are likely to see a rapidly growing market around artificial intelligence tools for medical imaging, a new report predicts. The market for artificial intelligence (AI) tools to process and analyze medical imaging [...]

Tuberculosis is a killer, but scientists are fighting back with nanobots

Tuberculosis, a bacterial disease which predominantly affects the lungs, isn’t all that common a sight in the United States. On average, fewer than 10,000 cases are reported each year in a country with [...]

Integrated sensor could monitor brain aneurysm treatment

Implantation of a stent-like flow diverter can offer one option for less invasive treatment of brain aneurysms – bulges in blood vessels – but the procedure requires frequent monitoring while the vessels heal. Now, [...]

2018-07-23T13:53:14+00:00

Leave A Comment